Drug Profile
Research programme: antifungals - F2G
Alternative Names: F3; F3 series; FG-3409Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator F2G
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Aspergillosis; Mycoses
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Aspergillosis in United Kingdom (IV)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Aspergillosis in United Kingdom (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Mycoses in United Kingdom (IV)